Transforming healthcare through transformative therapies
Johnson & Johnson Innovative Medicine is the FDA labeler of record for Darzalex, Stelara, Tremfya and others. 2 of its brands bill under a HCPCS code: Darzalex (J9145), Stelara (J3357).
Each brand opens the FDA registry filtered to that product.
Clinician-administered products from this labeler that carry a HCPCS code.